PMC:7417114 / 33352-33680 JSONTXT 11 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T260 0-47 Sentence denotes Osimertinib is a potent inhibitor of EGFR (60).
T261 48-215 Sentence denotes Osimertinib was reported (unpublished results; preprint) to be one of 24 FDA-approved drugs to show in vitro activity against SARS-CoV-2 (0.1 μM<IC50<10 μM)) (BioRxiv.
T262 216-253 Sentence denotes 10.1101/2020.03.20.999730) (Table 1).
T263 254-328 Sentence denotes Osimertinib has been approved for non-small cell lung carcinoma (Table 2).